Nektar Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NKTR and other ETFs, options, and stocks.

About NKTR

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. 

CEO
Howard W. Robin
CEOHoward W. Robin
Employees
61
Employees61
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
1990
Founded1990
Employees
61
Employees61

NKTR Key Statistics

Market cap
1.07B
Market cap1.07B
Price-Earnings ratio
-6.55
Price-Earnings ratio-6.55
Dividend yield
Dividend yield
Average volume
706.49K
Average volume706.49K
High today
$59.90
High today$59.90
Low today
$56.10
Low today$56.10
Open price
$57.99
Open price$57.99
Volume
472.14K
Volume472.14K
52 Week high
$62.95
52 Week high$62.95
52 Week low
$6.48
52 Week low$6.48

NKTR News

Simply Wall St 2d
How Investors Are Reacting To Nektar Therapeutics Securing FDA Fast Track For Eczema Drug Candidate

In recent news, Nektar Therapeutics announced that its lead candidate, rezpegaldesleukin, received Fast Track Designation from the FDA following strong performa...

How Investors Are Reacting To Nektar Therapeutics Securing FDA Fast Track For Eczema Drug Candidate
Nasdaq 2d
This Stock Is Up By 285% This Year But Could Still Jump By 53%, According to Wall Street

Key Points Nektar Therapeutics' leading candidate is performing well so far in phase 2 studies. This medicine could disrupt the large and competitive eczema t...

This Stock Is Up By 285% This Year But Could Still Jump By 53%, According to Wall Street

Analyst ratings

75%

of 8 ratings
Buy
75%
Hold
12.5%
Sell
12.5%

People also own

Based on the portfolios of people who own NKTR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.